
    
      This study will be an open-lable, phase â…  study and will evaluate the safety and
      pharmacokinetics of WX390 after a single administration followed by a 28-day continuous
      course of therapy; evaluate the safety and preliminary efficacy in an open-lable
      administration of WX390 at the MTD.
    
  